platycodin d has been researched along with Thyroid Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, B; Sun, M | 1 |
1 other study(ies) available for platycodin d and Thyroid Neoplasms
| Article | Year |
|---|---|
Platycodin D inhibits the malignant progression of papillary thyroid carcinoma by NF-κB and enhances the therapeutic efficacy of pembrolizumab.
Topics: Antibodies, Monoclonal, Humanized; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; NF-kappa B; Saponins; Thyroid Cancer, Papillary; Thyroid Neoplasms; Triterpenes | 2022 |